Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Praeruptorin A: Mechanistic Benchmarks for Inflammation Rese
2026-06-15
Praeruptorin A, an angular pyranocoumarin compound, demonstrates robust anti-inflammatory and ferroptosis-inhibiting effects via multi-targeted molecular modulation. It downregulates key cytokines and pathways implicated in macrophage-driven inflammation and shows application potential in ulcerative colitis and cancer metastasis models.
-
Stattic: STAT3 Inhibitor for HNSCC Research and Radiosensiti
2026-06-15
Stattic is a selective STAT3 inhibitor that enables precise dissection of STAT3-mediated signaling, apoptosis induction, and radiosensitization in head and neck squamous cell carcinoma (HNSCC) research. This article delivers actionable workflows, troubleshooting strategies, and translational insights for maximizing the impact of Stattic, featuring protocol optimization rooted in the latest mechanistic advances.
-
Methicillin Sodium Salt: Advanced Workflows for MSSA Researc
2026-06-14
Methicillin sodium salt empowers laboratories to design highly controlled Staphylococcus aureus infection models and resistance profiling assays. This guide translates state-of-the-art research and product specifications into actionable protocols, troubleshooting tips, and comparative insights for gram-positive infection workflows.
-
siRNA Nanoparticles Target TDRD9 to Mitigate P. aeruginosa L
2026-06-13
This study demonstrates that hyaluronic acid-coated siRNA nanoparticles targeting Tudor domain-containing protein 9 (TDRD9) promote neutrophil cuproptosis, reducing lung injury in preclinical Pseudomonas aeruginosa pneumonia models. The findings advance understanding of neutrophil-mediated immune modulation and highlight a promising therapeutic platform for multidrug-resistant bacterial infections.
-
Grazoprevir/Elbasvir: Efficacy and Advances in HCV Genotype
2026-06-12
This review evaluates the fixed-dose combination of Grazoprevir (MK-5172 hydrate) and Elbasvir for hepatitis C virus infection, highlighting its potent antiviral activity and favorable safety in diverse patient groups. The findings inform both clinical and laboratory research on direct-acting antivirals, especially for challenging populations such as those with HIV coinfection or chronic kidney disease.
-
CHIR-99021 (CT99021): Optimizing Stem Cell and Differentiati
2026-06-12
CHIR-99021 (CT99021) stands apart as a selective GSK-3 inhibitor empowering precise Wnt/β-catenin pathway modulation in stem cell research and regenerative models. This article delivers a protocol-driven perspective, practical troubleshooting, and actionable insights grounded in recent mechanistic findings and benchmarked use-cases.
-
TCAIM Regulates Mitochondrial Metabolism by Targeting OGDH
2026-06-11
Wang et al. (2025) identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, thereby modulating mitochondrial metabolism and energy production. This study unveils a noncanonical, post-translational mechanism for controlling a key TCA cycle enzyme, with implications for targeted metabolic research and disease modeling.
-
Fenofibrate: PPARα Agonist Mechanisms and Age-Independent Ef
2026-06-11
Fenofibrate is a potent PPARα agonist that activates the PPARα-YAP pathway in both adult and aging mice, inducing liver enlargement without age-dependent differences. This article details its mechanism, experimental benchmarks, and caveats for lipid metabolism and cancer biology research.
-
Sulfachloropyridazine Modulates Cecal Microbiota in Eimeria
2026-06-10
The referenced study investigates how sulfachlorpyridazine, ethanamizuril, and their combination reshape the cecal microbiota and metabolome in chickens infected with Eimeria tenella. By integrating 16S rRNA sequencing and metabolomics, the research reveals how these interventions influence microbial community structure and metabolic responses, informing future avian infection models and therapeutic strategies.
-
ECL Chemiluminescent Substrate Detection Kit: Enhanced Assay
2026-06-10
The ECL Chemiluminescent Substrate Detection Kit (Enhanced) from APExBIO delivers ultra-sensitive western blot chemiluminescence detection, making it ideal for low-abundance protein quantification and robust antibody detection assays. This guide bridges practical workflow improvements and troubleshooting strategies to maximize signal amplification and reproducibility across advanced protein immunodetection studies.
-
O-GlcNAcylation Regulates Wnt-Driven Bone Formation via Glyc
2026-06-09
This study reveals that O-GlcNAcylation is essential for Wnt-stimulated bone formation by regulating aerobic glycolysis in osteoblasts. The findings clarify metabolic mechanisms underpinning osteogenesis and suggest new targets for osteoporosis therapies.
-
Wnt and BMP Pathways Pattern Neuroectoderm in Hemichordates
2026-06-09
This study reveals how Wnt and BMP signaling gradients orchestrate anterior neuroectoderm development in the indirect-developing hemichordate Ptychodera flava. By dissecting spatial and temporal gene expression, the work clarifies evolutionarily conserved mechanisms of axis patterning in deuterostomes, informing both developmental biology and translational research on Wnt signaling modulation.
-
Dissecting In Vitro Metrics for Cancer Drug Response Evaluat
2026-06-08
Schwartz (2022) advances cancer drug evaluation by distinguishing between relative and fractional viability in in vitro assays, clarifying how drugs like Salinomycin impact proliferation versus cell death. These insights guide the design and interpretation of preclinical anti-cancer studies, improving reproducibility and the mechanistic understanding of drug actions.
-
ICG001: Precision Wnt/β-Catenin Inhibition for Translational
2026-06-08
Explore how ICG001, a selective Wnt/β-catenin pathway inhibitor, empowers translational researchers to dissect CBP/β-catenin-driven mechanisms in cancer, fibrosis, and regenerative biology. This thought-leadership article integrates mechanistic insight, protocol guidance, and strategic vision, referencing the latest advances in Wnt signaling modulation and highlighting APExBIO’s product innovation.
-
Sphingolipid Synthesis Inhibition Mitigates Ferroptosis via
2026-06-07
Liu et al. reveal that inhibiting sphingolipid synthesis with myriocin significantly reduces ferroptosis in neuronal cells by activating the HIF-1 pathway, specifically through HIF1α stabilization. This discovery identifies a novel neuroprotective mechanism with implications for mitigating regulated cell death in neurological disease models.